178 related articles for article (PubMed ID: 27329321)
1. Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
Hofer T; Perry G
J Trace Elem Med Biol; 2016 Dec; 38():1-9. PubMed ID: 27329321
[TBL] [Abstract][Full Text] [Related]
2. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.
Raha AA; Vaishnav RA; Friedland RP; Bomford A; Raha-Chowdhury R
Acta Neuropathol Commun; 2013 Sep; 1():55. PubMed ID: 24252754
[TBL] [Abstract][Full Text] [Related]
3. Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.
Lu LN; Qian ZM; Wu KC; Yung WH; Ke Y
Mol Neurobiol; 2017 Sep; 54(7):5213-5224. PubMed ID: 27578012
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
Du F; Qian ZM; Luo Q; Yung WH; Ke Y
Mol Neurobiol; 2015 Aug; 52(1):101-14. PubMed ID: 25115800
[TBL] [Abstract][Full Text] [Related]
5. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
[TBL] [Abstract][Full Text] [Related]
6. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
[TBL] [Abstract][Full Text] [Related]
7. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Hyperlipidemia on Endothelial Function of FPN1 Tek-Cre Mice and the Intervention Effect of Tetramethylpyrazine.
Sun MY; Zhang M; Chen SL; Zhang SP; Guo CY; Wang JS; Liu X; Miao Y; Yin HJ
Cell Physiol Biochem; 2018; 47(1):119-128. PubMed ID: 29763925
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and metallothioneins as molecular base for sex-dependent differences in clinical course of experimental autoimmune encephalomyelitis in chronic iron overload.
Ćurko-Cofek B; Grubić Kezele T; Barac-Latas V
Med Hypotheses; 2017 Sep; 107():51-54. PubMed ID: 28915963
[TBL] [Abstract][Full Text] [Related]
10. Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction.
Lee HJ; Choi JS; Lee HJ; Kim WH; Park SI; Song J
J Nutr Biochem; 2015 Dec; 26(12):1414-23. PubMed ID: 26383538
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung Disease.
Neves J; Leitz D; Kraut S; Brandenberger C; Agrawal R; Weissmann N; Mühlfeld C; Mall MA; Altamura S; Muckenthaler MU
EBioMedicine; 2017 Jun; 20():230-239. PubMed ID: 28499927
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
Chaudhary S; Ashok A; McDonald D; Wise AS; Kritikos AE; Rana NA; Harding CV; Singh N
J Alzheimers Dis; 2021; 82(4):1487-1497. PubMed ID: 34180415
[TBL] [Abstract][Full Text] [Related]
13. [Expression Changes of Hepcidin and Ferroportin 1 in Murine Model of Iron Overload].
Wang JW; Xu LH; Yao X; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):936-940. PubMed ID: 28641663
[TBL] [Abstract][Full Text] [Related]
14. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells.
Lunova M; Schwarz P; Nuraldeen R; Levada K; Kuscuoglu D; Stützle M; Vujić Spasić M; Haybaeck J; Ruchala P; Jirsa M; Deschemin JC; Vaulont S; Trautwein C; Strnad P
J Pathol; 2017 Jan; 241(1):104-114. PubMed ID: 27741349
[TBL] [Abstract][Full Text] [Related]
18. Iron Homeostasis Disorder and Alzheimer's Disease.
Peng Y; Chang X; Lang M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830326
[TBL] [Abstract][Full Text] [Related]
19. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
Castellani RJ; Honda K; Zhu X; Cash AD; Nunomura A; Perry G; Smith MA
Ageing Res Rev; 2004 Jul; 3(3):319-26. PubMed ID: 15231239
[TBL] [Abstract][Full Text] [Related]
20. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease.
Becerril-Ortega J; Bordji K; Fréret T; Rush T; Buisson A
Neurobiol Aging; 2014 Oct; 35(10):2288-301. PubMed ID: 24863668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
